Financial News Feed

The following slide deck was published by Tyme Technologies, Inc. in conjunction with this event....

Read more

Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will participate at the Oppenheimer Oncology Insight Summit in New York on Thursday, May 16, 2019. In one-on-one settings, the company will present its corporate...

Read more

Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the SunTrust Robinson Humphrey’s 5th Annual Life sciences Summit in New York on May 7th. In one-on-one settings, the company will present...

Read more

No summary available....

Read more

Interested investors might be taking a look at the medium range signals for Tyme Technologies (TYME). The reading from the 40-day commodity channel index is currently Sell. The CCI indicator is mainly...

Read more

We will be comparing the differences between Akebia Therapeutics Inc. (NASDAQ:AKBA) and Tyme Technologies Inc. (NASDAQ:TYME) as far as risk, analyst recommendations, profitability, institutional owner...

Read more

As Biotechnology companies, Tyme Technologies Inc. (NASDAQ:TYME) and Acorda Therapeutics Inc. (NASDAQ:ACOR) are our subject to compare. And more specifically their risk, analyst recommendations, profi...

Read more

Here will take a quick scan of Earnings Yield information on shares of PRGX Global, Inc. (NasdaqGS:PRGX). Currently, the Earnings to Price (Yield) is 0.025126, Earnings Yield is 0.028033, and Earnings...

Read more

Investors may be diving into the latest company earnings reports trying to scope out some quality stocks to add to the portfolio. Nobody knows for sure which way overall market momentum will sway as w...

Read more

We are comparing ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) and Tyme Technologies Inc. (NASDAQ:TYME) on their profitability, institutional ownership, analyst recommendations, risk, dividends, earnin...

Read more

iBio Inc. (NYSEAMERICAN:IBIO) and Tyme Technologies Inc. (NASDAQ:TYME), both competing one another are Biotechnology companies. We will contrast their risk, analyst recommendations, profitability, div...

Read more

This is a contrast between Mesoblast Limited (NASDAQ:MESO) and Tyme Technologies Inc. (NASDAQ:TYME) based on their risk, analyst recommendations, profitability, dividends, institutional ownership, ear...

Read more

resTORbio Inc. (NASDAQ:TORC) and Tyme Technologies Inc. (NASDAQ:TYME), are influenced by compare since they are both players in the Biotechnology. These...

Read more

Tyme Technologies (TYME) has ended the week in the red, yielding negative results for the shares at they ticked -14.56%. In taking a look at recent performance, we can see that shares have moved -27.5...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank